Can we use serum SCUBE 1 levels as a biomarker in obstructive sleep apnea hypopnea syndrome?

Selcuk O. T., Yilmaz G. O., Ellidag H. Y., Ilden O., Selcuk N. T., Yilmaz G., ...Daha Fazla

CRANIO-THE JOURNAL OF CRANIOMANDIBULAR & SLEEP PRACTICE, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1080/08869634.2021.2005917
  • Dergi Adı: CRANIO-THE JOURNAL OF CRANIOMANDIBULAR & SLEEP PRACTICE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, CINAHL, EMBASE, MEDLINE
  • Anahtar Kelimeler: Platelet activation, obstructive sleep apnea syndrome, SCUBE1, biomarker
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Objective To examine the SCUBE1 level, a biomarker in vascular biology that could determine the prognosis of cardiovascular events during OSA treatment. Methods In total, 129 patients were included in the study. Thirty were diagnosed with simple snoring and 99 with OSA. Results In males, significant correlation was determined between SCUBE1 non-REM AHI, hypopnea index, total apnea index, mean SO2, minimum SO2, and < 90% saturation duration. Conclusion Serum SCUBE1 levels increased more in male patients with severe OSA compared to other OSA levels, and high serum SCUBE1 levels were found to be associated with lower oxygen levels in OSA patients. The SCUBE1 biomarker can correlate with severe OSA in males. There was a statistically significant difference between OSA groups in terms of SCUBE1 score for male patients (p = 0.002) but not for females (p = 0.498). It is important that future SCUBE1 studies evaluate males vs. females.